Results 231 to 240 of about 338,121 (356)
Reply to: Concerns regarding interpretation and reporting in Kolivas et al. mHealth low carbohydrate dietary intervention in T2D. [PDF]
Kolivas D, Moschonis G.
europepmc +1 more source
HbA1c and Diabetes: Mismatches and Misclassifications
openaire +3 more sources
ABSTRACT Objective This meta‐analysis evaluates the safety and efficacy of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) for the treatment of older adults with obesity compared to younger individuals. Methods A systematic review was conducted following PRISMA guidelines (PROSPERO CRD420251074381).
Inês Rego de Figueiredo +4 more
wiley +1 more source
Frequency of HbA1c test requests in primary care: an analysis of hospital laboratory data
Jennifer Hirst +4 more
openalex +1 more source
Impact of HbA1c Criterion on the Detection of Subjects with Increased Risk for Diabetes among Health Check-Up Recipients in Korea [PDF]
Hong‐Kyu Kim +2 more
openalex +1 more source
ABSTRACT Objective This study aimed to evaluate whether reduced‐frequency dosing of GLP1 receptor agonists maintains weight loss, body composition, and metabolic syndrome improvements following successful initial treatment with standard weekly therapy. Methods This retrospective case series included 30 adults who achieved weight plateau while on weekly
Michelle Wong +3 more
wiley +1 more source
ABSTRACT Objective This study compared population characteristics and overall US prevalence of obesity over time using the BMI criteria and the 2025 Lancet Commission criteria (i.e., the Excess Adiposity criteria). Methods We analyzed data from 58,053 adults aged ≥ 20 years in the National Health and Nutrition Examination Survey from 1999 to 2023.
Jennifer H. Hwang, Neda Laiteerapong
wiley +1 more source
Alanine Aminotransferase Elevation at Diagnosis of Youth-Onset Type 2 Diabetes: Prevalence, Predictors, and One-Year Outcomes. [PDF]
DeLacey S +5 more
europepmc +1 more source

